Name | N-[4-({5-[3-(2-Furylmethyl)-4-oxo-1,2,3,4-tetrahydro-2-quinazolinyl]-2-methoxybenzyl}oxy)-3,5-dimethylphenyl]acetamide |
---|---|
Synonyms |
N-[4-({5-[3-(2-Furylmethyl)-4-oxo-1,2,3,4-tetrahydro-2-quinazolinyl]-2-methoxybenzyl}oxy)-3,5-dimethylphenyl]acetamide
Acetamide, N-[4-[[5-[3-(2-furanylmethyl)-1,2,3,4-tetrahydro-4-oxo-2-quinazolinyl]-2-methoxyphenyl]methoxy]-3,5-dimethylphenyl]- ML-224 ML224 |
Description | ML224(NCGC00242364; ANTAG3) is a selective TSHR inverse agonist; inhibits TSH-stimulated cAMP production with an IC50 = 2.3 μM.IC50 value: 2.3 uM [1]Target: TSHR agonistin vitro: ANTAG3 was selective for TSHR inhibition; half-maximal inhibitory doses were 2.1 μM for TSHR and greater than 30 μM for LH and FSH receptors [2]. in vivo: In mice treated with TRH, ANTAG3 lowered serum free T4 by 44% and lowered mRNAs for sodium-iodide cotransporter and thyroperoxidase by 75% and 83%, respectively. In mice given M22, ANTAG3 lowered serum free T4 by 38% and lowered mRNAs for sodium-iodide cotransporter and thyroperoxidase by 73% and 40%, respectively [2]. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 752.3±60.0 °C at 760 mmHg |
Molecular Formula | C31H31N3O5 |
Molecular Weight | 525.595 |
Flash Point | 408.8±32.9 °C |
Exact Mass | 525.226379 |
LogP | 2.92 |
Vapour Pressure | 0.0±2.5 mmHg at 25°C |
Index of Refraction | 1.626 |
Storage condition | 2-8℃ |